Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine
Oncologist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Oncologist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Cardiologist
MBBS, FCPS (Medicine), FCPS (Cardiology)
Gastroenterologist
M.B.B.S. , F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.D, F.C.P.S (Gastroenterology)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures